arginine has been researched along with linagliptin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diessel, S; Forst, T; Jahnke, J; Kapitza, C; Michelson, G | 1 |
| Aberer, F; Brodmann, M; Dimsity, G; Hafner, F; Hödl, R; Hutz, B; Meinitzer, A; Riedl, R; Sourij, H; Stojakovic, T; Tripolt, NJ; Url, J | 1 |
| Aberer, F; Aziz, F; Brachtl, G; Brodmann, M; Dimsity, G; Hafner, F; Hödl, R; Meinitzer, A; Riedl, R; Sourij, H; Stojakovic, T; Strunk, D; Tripolt, NJ; Url, J | 1 |
3 trial(s) available for arginine and linagliptin
| Article | Year |
|---|---|
Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients.
Topics: Aged; Arginine; Arterial Pressure; C-Reactive Protein; Cyclic GMP; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypertension; Linagliptin; Male; Microvessels; Middle Aged; Regional Blood Flow; Retinal Vessels; Transforming Growth Factor beta1 | 2016 |
The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Austria; Biological Availability; Biomarkers; Brachial Artery; Clinical Protocols; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Humans; Linagliptin; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Topics: Aged; Arginine; Austria; Biomarkers; Blood Glucose; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Linagliptin; Lipids; Male; Middle Aged; Ornithine; Postprandial Period; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation | 2018 |